Skip to main content
SpringerLink
Log in

Considerations in Monitoring and Controlling Pharmaceutical Manufacturing

  • Chapter
  • First Online:
Pharmaco-Complexity

Part of the book series: Outlines in Pharmaceutical Sciences ((OIPS,volume 1))

  • 796 Accesses

Abstract

Pharmaceutical manufacturing is by definition a complex activity and is perhaps one of the most thoroughly studied activities from this perspective in product development (Hickey and Ganderton 2010).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Agatanovic-Kustrin S, Berseford R (2000) Basic concepts of artificial neural network (ANN) modeling and its application to pharmaceutical research. J Pharm Biomed Anal 22:717–727

    Article  Google Scholar 

  • Ashanta AS, Kowalski JG, Rhodes CT (1995) Artificial neural networks: implications for pharmaceutical sciences. Drug Dev Ind Pharm 21:119–155

    Article  Google Scholar 

  • Borquin J (1997) Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development. Pharm Dev Technol 2:95–109

    Article  Google Scholar 

  • Box GEP, Hunter WG, Hunter JS (1978) Statistics for experimenters: an introduction to design, data analysis, and model building. Wiley, New York

    Google Scholar 

  • Cochran WG, Cox GM (1957) Experimental designs, 2nd edn. Wiley, New York

    Google Scholar 

  • Hickey AJ, Ganderton D (2010) Pharmaceutical process engineering, 2nd edn. Informa Healthcare, New York

    Google Scholar 

  • Lapore J, Spavins J (2008) PQLI design space. J Pharm Innov 3:79–87

    Article  Google Scholar 

  • Nosal R, Schultz T (2008) PQLI definition of criticality. J Pharm Innov 3:69–78

    Article  Google Scholar 

  • Takayama K, Fujikawa M, Nagai T (1999) Artificial neural network (ANN) as a novel method to optimize pharmaceutical formulation. Pharm Res 16:1–6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, 27599, USA

    Anthony J. Hickey Ph.D.

  2. University of Texas, Austin, TX, 78712, USA

    Hugh D. C. Smyth Ph.D.

Authors
  1. Anthony J. Hickey Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hugh D. C. Smyth Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony J. Hickey Ph.D. .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Hickey, A.J., Smyth, H.D.C. (2011). Considerations in Monitoring and Controlling Pharmaceutical Manufacturing. In: Pharmaco-Complexity. Outlines in Pharmaceutical Sciences, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7856-1_4

Download citation

Publish with us

Policies and ethics

Societies and partnerships

Search

Navigation